Sally Snyder

1.7k total citations
16 papers, 1.3k citations indexed

About

Sally Snyder is a scholar working on Infectious Diseases, Virology and Literature and Literary Theory. According to data from OpenAlex, Sally Snyder has authored 16 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 11 papers in Virology and 2 papers in Literature and Literary Theory. Recurrent topics in Sally Snyder's work include HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (11 papers). Sally Snyder is often cited by papers focused on HIV Research and Treatment (11 papers), HIV/AIDS Research and Interventions (11 papers) and HIV/AIDS drug development and treatment (11 papers). Sally Snyder collaborates with scholars based in United States, Philippines and Italy. Sally Snyder's co-authors include Robert L. Murphy, Gregory K. Robbins, Robert W. Shafer, William A. Meyer, Roy M. Gulick, Edward P. Acosta, Karin L. Klingman, Laura Smeaton, Michael P. Dubé and Daniel R. Kuritzkes and has published in prestigious journals such as New England Journal of Medicine, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sally Snyder

16 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sally Snyder United States 11 1.1k 940 349 139 90 16 1.3k
Peter Gute Germany 18 868 0.8× 688 0.7× 216 0.6× 308 2.2× 88 1.0× 35 1.2k
Stephen Kravcik Canada 11 666 0.6× 668 0.7× 216 0.6× 206 1.5× 53 0.6× 17 941
Martin S. Hirsch United States 7 1.2k 1.1× 1.1k 1.2× 130 0.4× 458 3.3× 58 0.6× 7 1.6k
Carla Pettinelli United States 10 775 0.7× 653 0.7× 135 0.4× 173 1.2× 28 0.3× 10 968
Clare Brennan United States 13 1.3k 1.2× 1.0k 1.1× 346 1.0× 299 2.2× 32 0.4× 20 1.6k
Stephen Becker United States 18 654 0.6× 440 0.5× 164 0.5× 199 1.4× 153 1.7× 33 974
Christina M. Lalama United States 17 765 0.7× 862 0.9× 194 0.6× 178 1.3× 77 0.9× 36 1.2k
Nicola Gianotti Italy 21 1.2k 1.1× 1.1k 1.2× 305 0.9× 306 2.2× 72 0.8× 153 1.5k
Gerd Fätkenheuer Germany 14 576 0.5× 528 0.6× 194 0.6× 209 1.5× 155 1.7× 38 908
Michael Wohlfeiler United States 14 758 0.7× 637 0.7× 209 0.6× 280 2.0× 43 0.5× 31 1.1k

Countries citing papers authored by Sally Snyder

Since Specialization
Citations

This map shows the geographic impact of Sally Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sally Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sally Snyder more than expected).

Fields of papers citing papers by Sally Snyder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sally Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sally Snyder. The network helps show where Sally Snyder may publish in the future.

Co-authorship network of co-authors of Sally Snyder

This figure shows the co-authorship network connecting the top 25 collaborators of Sally Snyder. A scholar is included among the top collaborators of Sally Snyder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sally Snyder. Sally Snyder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Stone, Nimalie D., Shelia B. Dunaway, Charles Flexner, et al.. (2007). Multiple-Dose Escalation Study of the Safety, Pharmacokinetics, and Biologic Activity of Oral AMD070, a Selective CXCR4 Receptor Inhibitor, in Human Subjects. Antimicrobial Agents and Chemotherapy. 51(7). 2351–2358. 103 indexed citations
2.
Benson, Constance A., Florin Vaida, Diane V. Havlir, et al.. (2006). A Randomized Trial of Treatment Interruption before Optimized Antiretroviral Therapy for Persons with Drug‐Resistant HIV: 48‐Week Virologic Results of ACTG A5086. The Journal of Infectious Diseases. 194(9). 1309–1318. 18 indexed citations
3.
Dubé, Michael P., Robert A. Parker, Pablo Tebas, et al.. (2005). Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS. 19(16). 1807–1818. 157 indexed citations
4.
Gulick, Roy M., Heather J. Ribaudo, Cecilia M. Shikuma, et al.. (2004). Triple-Nucleoside Regimens versus Efavirenz-Containing Regimens for the Initial Treatment of HIV-1 Infection. New England Journal of Medicine. 350(18). 1850–1861. 396 indexed citations
5.
Lustgarten, Stephanie, K. Squires, Edward P. Acosta, et al.. (2004). Triple nucleoside analogue vs. efavirenz-containing regimens for the initialtreatment of HIV infection: AIDS Clinical Trials Group (ACTG) Study A5095. 32–43. 11 indexed citations
6.
Robbins, Gregory K., Victor De Gruttola, Robert W. Shafer, et al.. (2003). Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection. New England Journal of Medicine. 349(24). 2293–2303. 272 indexed citations
7.
Shafer, Robert W., Laura Smeaton, Gregory K. Robbins, et al.. (2003). Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection. New England Journal of Medicine. 349(24). 2304–2315. 186 indexed citations
8.
Shafer, Robert W., Laura Smeaton, Gregory K. Robbins, et al.. (2003). AIDS CLINICAL TRIALS GROUP 384 TEAM. COMPARISON OF FOUR-DRUG REGIMENS AND PAIRS OF SEQUENTIAL THREE-DRUG REGIMENS AS INITIAL THERAPY FOR HIV-1 INFECTION. 349(24). 2304–2315. 9 indexed citations
9.
Smeaton, Laura, John G. Gerber, Edward P. Acosta, et al.. (2002). The Pharmacokinetics of Amprenavir, Zidovudine, and Lamivudine in the Genital Tracts of Men Infected with Human Immunodeficiency Virus Type 1 (AIDS Clinical Trials Group Study 850). The Journal of Infectious Diseases. 186(2). 198–204. 34 indexed citations
10.
Gulick, Roy M., X. Joan Hu, Susan A. Fiscus, et al.. (2002). Durability of Response to Treatment among Antiretroviral‐Experienced Subjects: 48‐Week Results from AIDS Clinical Trials Group Protocol 359. The Journal of Infectious Diseases. 186(5). 626–633. 11 indexed citations
11.
Gulick, Roy M., Laura Smeaton, Richard T. D'Aquila, et al.. (2001). Indinavir, Nevirapine, Stavudine, and Lamivudine for Human Immunodeficiency Virus–Infected, Amprenavir‐Experienced Subjects: AIDS Clinical Trials Group Protocol 373. The Journal of Infectious Diseases. 183(5). 715–721. 9 indexed citations
12.
13.
14.
Snyder, Sally. (1975). Quest for the Sacred in Northern Puget Sound: An Interpretation of Potlatch. Ethnology. 14(2). 149–149. 7 indexed citations
15.
Snyder, Sally. (1968). Stylistic Stratification in an Oral Tradition. Anthropologica. 10(2). 235–235. 1 indexed citations
16.
Snyder, Sally & Åke Hultkrantz. (1959). The North American Indian Orpheus Tradition. Journal of American Folklore. 72(284). 192–192. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Gute Breakdown of academic impact, for papers by Stephen Kravcik Breakdown of academic impact, for papers by Martin S. Hirsch Breakdown of academic impact, for papers by Carla Pettinelli Breakdown of academic impact, for papers by Clare Brennan Breakdown of academic impact, for papers by Stephen Becker Breakdown of academic impact, for papers by Christina M. Lalama Breakdown of academic impact, for papers by Nicola Gianotti Breakdown of academic impact, for papers by Gerd Fätkenheuer Breakdown of academic impact, for papers by Michael Wohlfeiler
Rankless by CCL
2026